Randolph Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-450,337
Closed -$18.5M 46
2019
Q2
$18.5M Buy
+450,337
New +$17.9M 3.18% 10
2017
Q3
Sell
-555,766
Closed -$17.7M 39
2017
Q2
$17.7M Hold
555,766
3.36% 13
2017
Q1
$18M Buy
555,766
+843
+0.2% +$26.6K 3.45% 12
2016
Q4
$17.1M Sell
554,923
-105
-0% -$3.21K 3.5% 11
2016
Q3
$17.8M Hold
555,028
4.5% 10
2016
Q2
$18.5M Hold
555,028
4.77% 7
2016
Q1
$15.6M Buy
555,028
+21,396
+4% +$611K 3.48% 15
2015
Q4
$16.3M Sell
533,632
-1,159
-0.2% -$36.5K 4.16% 12
2015
Q3
$15.9M Sell
534,791
-2
-0% -$64 3.82% 10
2015
Q2
$17M Buy
534,793
+520
+0.1% +$16.9K 3.84% 7
2015
Q1
$17.6M Sell
534,273
-30,566
-5% -$972K 3.83% 8
2014
Q4
$16.7M Buy
+564,839
New +$16.2M 3.23% 12

Other funds holding PFE

Randolph Company's PFE Position: Q3 2019 in Review

Randolph Company sold out of Pfizer (PFE) in Q3 2019, closing a stake of 450,337 shares — an estimated $18.5M sold.

Randolph Company first reported a position in PFE in Q4 2014 and held it in 12 quarters. The position peaked at $18.5M in Q2 2016. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Randolph Company reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
  • Randolph Company sold 450,337 Pfizer shares in Q3 2019, an estimated $18.5M.
  • Randolph Company first reported a position in Pfizer in Q4 2014 and held it in 12 quarters.
  • Randolph Company's Pfizer position peaked at $18.5M in Q2 2016.
  • 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Randolph Company's 13F filing for Q3 2019, filed 16 Oct 2019.